Lumipulse-Measured Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer Disease
This study provides Class II evidence that Lumipulse measures of p-tau181/Aβ42 in the CSF accurately discriminated cognitively normal participants with and without Alzheimer disease neuropathologic change.
Authors
- Jason Weller
- Justin M. Long (ORCID: https://orcid.org/0000-0003-0769-604X)
- Breton M. Asken
- Richard J. Perrin (ORCID: https://orcid.org/0000-0002-3443-7716)
- Kaj Blennow (ORCID: https://orcid.org/0000-0002-1890-4193)
- Thor D. Stein (ORCID: https://orcid.org/0000-0001-6954-4477)
- Ann Carolyn McKee (ORCID: https://orcid.org/0000-0003-2961-7488)
- Jenna R. Groh (ORCID: https://orcid.org/0000-0002-1831-9314)
- Michelle Safransky
- Gil Dan Rabinovici (ORCID: https://orcid.org/0000-0002-3626-4265)
- Michael L. Alosco (ORCID: https://orcid.org/0000-0002-8113-8428)
- Rachel L. Henson (ORCID: https://orcid.org/0000-0002-0664-0629)
- John C. Morris (ORCID: https://orcid.org/0000-0001-9820-5618)
- Suzanne E. Schindler (ORCID: https://orcid.org/0000-0002-1680-1465)
- Henrik Zetterberg (ORCID: https://orcid.org/0000-0003-3930-4354)
- Brett Martin
- Yorghos Tripodis (ORCID: https://orcid.org/0000-0003-2190-7608)
- Jesse Mez (ORCID: https://orcid.org/0000-0003-1438-5442)
- Wendy Wei Qiao Qiu
Institutions
- Boston University (US)
Publication Details
- Journal
- Neurology
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1212/wnl.0000000000209866
- Citations
- 6
- Primary Topic
- Spaceflight effects on biology
- Type
- article
- Field-Weighted Citation Impact
- 1.96
Funders
- Alzheimer's Association
- National Institutes of Health
- National Institute on Aging